Physical capacity modulates intestinal barrier dysfunction in functional disorders: phenotype-specific patterns in
Francesco Russo1, Antonella Bianco2, Laura Prospero1
1Functional Gastrointestinal Disorders Research Group, National Institute of Gastroenterology IRCCS "Saverio de Bellis", Castellana Grotte, Italy.
Background:
Intestinal barrier dysfunction is increasingly implicated in the pathophysiology of fibromyalgia (FM) and irritable bowel syndrome (IBS), particularly in their comorbid form. Physical capacity (PC) influences systemic inflammation and metabolic resilience, but its relationship with gut barrier integrity in these conditions remains poorly defined.
Methods:
We conducted a cross-sectional study of 56 patients with FM (n = 14), IBS (n = 23), or both (FM + IBS, n = 19). Intestinal barrier function was assessed using serum and fecal zonulin, intestinal fatty acid-binding protein (I-FABP), and the lactulose/mannitol (Lac/Man) urinary excretion test. PC was quantified using the Global Physical Capacity Score (GPCS). Clinical symptoms were evaluated using the Fibromyalgia Impact Questionnaire-Revised (FIQ-R) and IBS Severity Scoring System (IBS-SSS).
Results:
FM + IBS patients exhibited the greatest barrier dysfunction, with elevated fecal zonulin and Lac/Man ratio. IBS patients showed increased I-FABP, consistent with epithelial injury, whereas FM patients had milder gastrointestinal symptoms and less pronounced biomarker alterations. Although overall PC scores did not significantly differ across groups, serum zonulin levels showed a strong inverse correlation with GPCS. When stratified by GPCS (cut-off ≥6), patients in the high PC group exhibited significantly lower (p = 0.01) serum zonulin concentrations (48.23 ± 12.44 ng/mL) compared to those in the low PC group (57.63 ± 9.69 ng/mL). Multiple regression analysis confirmed GPCS as an independent predictor of serum zonulin (β = -9.67, p = 0.01), while BMI was not a significant contributor (p = 0.79). Furthermore, urinary indole levels correlated positively with both lactulose excretion and the Lac/Man ratio, supporting the existence of a dysbiosis-permeability feedback loop in these disorders.
Conclusion:
Intestinal barrier dysfunction in FM and IBS displays phenotype-specific patterns and is significantly modulated by PC. These findings support the integration of PC assessment into clinical phenotyping and highlight potential targets for personalized management of chronic overlapping pain syndromes.
More Related Videos
09:24Functional Assessment of Intestinal Permeability and Neutrophil Transepithelial Migration in Mice using a Standardized Intestinal Loop Model
Published on: February 11, 2021
05:14Assessment of Gut Barrier Integrity in Mice Using Fluorescein-Isothiocyanate-Labeled Dextran
Published on: November 18, 2022
Related Concept Videos
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:20Gastrointestinal Motility Disorders
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...